Transcription of POST-MI - RxFiles
{{id}} {{{paragraph}}}
post -MITroubleshooting Practical IssuesOctober 2004 The RxFiles Academic Detailing Programin collaboration withDerek Jorgenson, Health Quality Council (HQC)701 Queen StreetSaskatoon City HospitalSaskatoon, SK S7K 0M7 Phone 306-655-8506 ; Fax 306-655-7980 Email: Message: Four types of medication (ACE-Inhibitors, beta-blockers,statins & ASA) have been shown to reduce cardiovascularrisk in POST-MI patients. 1 These benefits are in addition torisk factor management (eg. diet 2,3,4, lifestyle, exercise) andoccur regardless of the presence of hypertension,dyslipidemia, or LV dysfunction. Clinical judgment isessential to assess risk/benefit for individual are we doing in Saskatchewan? An analysis of Saskatchewan dispensing rates by the HQCsuggests that important drugs are underutilized (See Figure 1).
POST-MI Troubleshooting Practical Issues October 2004 The RxFiles Academic Detailing Program in collaboration with Derek Jorgenson, Health Quality Council (HQC)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}